CoChat

Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index; none of the 34 sources its claims cite is checked for support yet.

Abstract

Chronic wounds are a major global health problem. Their management is difficult and costly, and the development of antibiotic resistance by both planktonic and biofilm-associated bacteria necessitates the use of alternative wound treatments. Honey is now being revisited as an alternative treatment due to its broad-spectrum antibacterial activity and the inability of bacteria to develop resistance to it. Many previous antibacterial studies have used honeys that are not well characterized, even in terms of quantifying the levels of the major antibacterial components present, making it difficult to build an evidence base for the efficacy of honey as an antibiofilm agent in chronic wound treatment. Here we show that a range of well-characterized New Zealand manuka-type honeys, in which two principle antibacterial components, methylglyoxal and hydrogen peroxide, were quantified, can eradicate biofilms of a range of Staphylococcus aureus strains that differ widely in their biofilm-forming abilities. Using crystal violet and viability assays, along with confocal laser scanning imaging, we demonstrate that in all S. aureus strains, including methicillin-resistant strains, the manuka-type honeys showed significantly higher anti-biofilm activity than clover honey and an isotonic sugar solution. We observed higher anti-biofilm activity as the proportion of manuka-derived honey, and thus methylglyoxal, in a honey blend increased. However, methylglyoxal on its own, or with sugar, was not able to effectively eradicate S. aureus biofilms. We also demonstrate that honey was able to penetrate through the biofilm matrix and kill the embedded cells in some cases. As has been reported for antibiotics, sub-inhibitory concentrations of honey improved biofilm formation by some S. aureus strains, however, biofilm cell suspensions recovered after honey treatment did not develop resistance towards manuka-type honeys. New Zealand manuka-type honeys, at the concentrations they can be applied in wound dressings are highly active in both preventing S. aureus biofilm formation and in their eradication, and do not result in bacteria becoming resistant. Methylglyoxal requires other components in manuka-type honeys for this anti-biofilm activity. Our findings support the use of well-defined manuka-type honeys as a topical anti-biofilm treatment for the effective management of wound healing.

Overview

CoChat Summary

TL;DR

Well-characterized New Zealand manuka-type honeys prevented and eradicated *Staphylococcus aureus* biofilms, including MRSA strains, more effectively than clover honey or an isotonic sugar solution. Methylglyoxal alone or with sugar did not reproduce the anti-biofilm activity, indicating other honey components are required.

Key findings

  • Manuka-type honeys inhibited planktonic growth and biofilm formation: 8% manuka honey and Medihoney, 16% manuka/kanuka honey, and 32% clover honey completely inhibited growth of all four *S. aureus* strains; the sugar solution only inhibited MW2 at 32%. Manuka honey at 8% reduced NCTC 8325 biofilm formation by ∼95%, while Medihoney and manuka/kanuka honey achieved ∼95% prevention at 16%.
  • Manuka honey was most effective against established biofilms, eliminating almost all biofilm mass at 16%–32%; Medihoney and manuka/kanuka honey were consistently effective across all four strains only at 32%. Clover honey and sugar solution did not significantly reduce established biofilm mass until 32%, and sugar solution did not remove USA300 biofilm at 32%.
  • Honey killed cells within biofilms: after 8% manuka honey, only ∼10% of cells were viable in remaining ATCC 25923 and USA300 biofilms, no ATP was detected from MW2, and NCTC 8325 viability was reduced by ∼80% even though biofilm biomass was unaffected. CLSM showed 32% manuka honey reduced Syto9-stained live biofilm biomass to 10%.
  • MGO alone or with sugar did not effectively eradicate established biofilms; MGO at levels equivalent to 1–8% manuka/kanuka honey increased NCTC 8325 biofilm biomass ∼2-fold, and no tested MGO concentration (1–32%) significantly reduced established biofilm biomass. Sub-inhibitory honey enhanced biofilm formation in some strains (NCTC 8325: 1.5- and 2-fold with manuka and manuka/kanuka honey), but cells recovered after honey treatment did not develop resistance.

Methods

  • Four well-characterized NZ honeys (monofloral manuka, Medihoney, manuka/kanuka, clover) plus an isotonic sugar solution were tested; MGO, DHA, and H₂O₂ levels were quantified. Four *S. aureus* strains were used: NCTC 8325 and ATCC 25923 (methicillin-sensitive), MW2 (HA-MRSA), and USA300 (CA-MRSA).
  • Static crystal violet assays measured biofilm formation and elimination; BacTitre Glo ATP luminescence measured cell viability in biofilms; CLSM with Syto9/propidium iodide and COMSTAT quantified live/dead biofilm biomass. Resistance was assessed by recovering cells after sub-eliminatory honey treatment and testing growth and biofilm formation.
  • Statistical analysis used D’Agostino-Pearson normality tests followed by One-Way ANOVA with Tukey test, significance at p < 0.05; assays generally used three biological replicates with three technical repeats.

Limitations

  • The paper notes that incomplete displacement of Syto9 by propidium iodide means some dead cells retain Syto9 staining, so absolute live-cell levels detected in the Syto9 channel are somewhat overestimated. It also reports the BacTitre Glo detection limit at a luminescence reading below 1,000, equivalent to 10³ CFU/well, with no upper limit detected.
  • Evident from the text: all experiments are in vitro static biofilm assays in microtitre plates, not animal or clinical wound models, so the findings do not directly demonstrate efficacy in chronic wounds.
  • Evident from the text: the study tests a limited set of four *S. aureus* strains and four NZ honey samples, so generalizability to other strains, honey sources, or wound pathogens is not established.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.7717/peerj.326

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Correlation of levels of intracellular ATP to colony forming units (CFU) in static biofilms of S. aureus. Static biofilms of S. aureus were formed in the wells of a microtitre plate for 48 h (with media replenishment at 24 h). After removal of the biofilm from the wall of each well, intracellular ATP levels were measured by the BacTitre Glo Viability Kit and CFU were determined for each well. The intracellular levels of ATP are plotted as a function of CFU and validate that the BacTitre Glo Viability Kit can be used as a surrogate measure of biofilm cell viability in subsequent assays.
Figure 1 Correlation of levels of intracellular ATP to colony forming units (CFU) in static biofilms of S. aureus. Static biofilms of S. aureus were formed in the wells of a microtitre plate for 48 h (with media replenishment at 24 h). After removal of the biofilm from the wall of each well, intracellular ATP levels were measured by the BacTitre Glo Viability Kit and CFU were determined for each well. The intracellular levels of ATP are plotted as a function of CFU and validate that the BacTitre Glo Viability Kit can be used as a surrogate measure of biofilm cell viability in subsequent assays.CC BY · PubMed Central
Figure 2 Quantification of biofilm formation by different strains of S. aureus. The ability of different strains of S. aureus to form biofilms on the plastic surface of tissue-culture treated 96-well microtitre plate was assessed in TSB(G) at 24 h and 48 h. Biofilm adherence was determined using a static biofilm formation assay over 24 h (A) and 48 h (with media replenished after 24 h incubation) (B). Biofilm formation was quantified by staining with 0.2% crystal violet solution and measured at an optical density of 595 nm. Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate, *** represents p < 0.001, compared to NCTC 8325, as assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.
Figure 2 Quantification of biofilm formation by different strains of S. aureus. The ability of different strains of S. aureus to form biofilms on the plastic surface of tissue-culture treated 96-well microtitre plate was assessed in TSB(G) at 24 h and 48 h. Biofilm adherence was determined using a static biofilm formation assay over 24 h (A) and 48 h (with media replenished after 24 h incubation) (B). Biofilm formation was quantified by staining with 0.2% crystal violet solution and measured at an optical density of 595 nm. Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate, *** represents p < 0.001, compared to NCTC 8325, as assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.CC BY · PubMed Central
Figure 3 Effects of NZ honeys and sugar on S. aureus biofilm formation. S. aureus biofilms were allowed to form in the presence of four different NZ honey types (manuka, Medihoney, manuka/kanuka or clover) or a sugar solution. Biofilm formation was assessed using a static biofilm formation assay with crystal violet staining to quantify biomass. S. aureus strains are: (A) NCTC 8325; (B) ATCC 25923; (C) MW2 (HA-MRSA) and (D) USA300 (CA-MRSA). Biofilm formation is expressed as a percentage relative to that produced by the untreated control, which is set at 100%. Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.
Figure 3 Effects of NZ honeys and sugar on S. aureus biofilm formation. S. aureus biofilms were allowed to form in the presence of four different NZ honey types (manuka, Medihoney, manuka/kanuka or clover) or a sugar solution. Biofilm formation was assessed using a static biofilm formation assay with crystal violet staining to quantify biomass. S. aureus strains are: (A) NCTC 8325; (B) ATCC 25923; (C) MW2 (HA-MRSA) and (D) USA300 (CA-MRSA). Biofilm formation is expressed as a percentage relative to that produced by the untreated control, which is set at 100%. Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.CC BY · PubMed Central
Figure 4 Effects of MGO on S. aureus biofilm formation. Biofilm formation by S. aureus NCTC 8325 grown in the presence of MGO and MGO plus sugar solution. MGO stock solutions were prepared to correspond to the MGO levels in undiluted manuka-type honeys (100 mg/kg of manuka/kanuka honey, 700 mg/kg of Medihoney, and 900 mg/kg of manuka-honey; Table 1). Biofilm formation was assessed using the described static assay with crystal violet staining to quantify biomass. Biofilm formation is expressed as a percentage relative to the untreated control, which is set at 100%. Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.
Figure 4 Effects of MGO on S. aureus biofilm formation. Biofilm formation by S. aureus NCTC 8325 grown in the presence of MGO and MGO plus sugar solution. MGO stock solutions were prepared to correspond to the MGO levels in undiluted manuka-type honeys (100 mg/kg of manuka/kanuka honey, 700 mg/kg of Medihoney, and 900 mg/kg of manuka-honey; Table 1). Biofilm formation was assessed using the described static assay with crystal violet staining to quantify biomass. Biofilm formation is expressed as a percentage relative to the untreated control, which is set at 100%. Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.CC BY · PubMed Central
Figure 5 Effects of NZ honeys on established S. aureus biofilms and cell viability within the biofilms. Established S. aureus NCTC 8325, ATCC 25923, MW2 and USA300 biofilms were treated with NZ honeys – manuka, Medihoney, manuka/kanuka, clover, and a sugar solution. The remaining biofilm masses were quantified using crystal violet staining (left y-axis) and cell viability within these remaining biofilms were assessed using the BacTitre Glo Viability Kit (right y-axis). Error bars represent ± standard deviation (SD) of three biological samples performed in triplicate Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.
Figure 5 Effects of NZ honeys on established S. aureus biofilms and cell viability within the biofilms. Established S. aureus NCTC 8325, ATCC 25923, MW2 and USA300 biofilms were treated with NZ honeys – manuka, Medihoney, manuka/kanuka, clover, and a sugar solution. The remaining biofilm masses were quantified using crystal violet staining (left y-axis) and cell viability within these remaining biofilms were assessed using the BacTitre Glo Viability Kit (right y-axis). Error bars represent ± standard deviation (SD) of three biological samples performed in triplicate Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.CC BY · PubMed Central
Figure 6 Effects of MGO on established S. aureus biofilms. S. aureus NCTC 8325 biofilms were treated with MGO and a combination of MGO and the sugar solution. MGO stock solutions were prepared to correspond to the MGO levels in undiluted honey (100 mg/kg of manuka/kanuka honey, 700 mg/kg of Medihoney, and 900 mg/kg of manuka honey; Table 1). The crystal violet stained residual biofilm mass after 24 h treatment was quantified using optical density (OD595 nm). Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.
Figure 6 Effects of MGO on established S. aureus biofilms. S. aureus NCTC 8325 biofilms were treated with MGO and a combination of MGO and the sugar solution. MGO stock solutions were prepared to correspond to the MGO levels in undiluted honey (100 mg/kg of manuka/kanuka honey, 700 mg/kg of Medihoney, and 900 mg/kg of manuka honey; Table 1). The crystal violet stained residual biofilm mass after 24 h treatment was quantified using optical density (OD595 nm). Error bars represent ±standard deviation (SD) of three biological samples performed in triplicate. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.CC BY · PubMed Central
Figure 7 Live/dead staining of different honey treated established biofilms. Established biofilms produced by S. aureus NCTC 8325 were treated with TSB containing honey (manuka, Medihoney, manuka/kanuka or clover) or sugar solution at 1%, 2%, 16%, and 32% (w/vol). Syto9 (green; viable cells) and propidium iodine (red; dead cells) stained images were acquired using Nikon A1 Confocal Laser Scanning Microscope. The 3D- images were reconstructed using NIS-elements (version 10). Scale bar represents 50 µ m.
Figure 7 Live/dead staining of different honey treated established biofilms. Established biofilms produced by S. aureus NCTC 8325 were treated with TSB containing honey (manuka, Medihoney, manuka/kanuka or clover) or sugar solution at 1%, 2%, 16%, and 32% (w/vol). Syto9 (green; viable cells) and propidium iodine (red; dead cells) stained images were acquired using Nikon A1 Confocal Laser Scanning Microscope. The 3D- images were reconstructed using NIS-elements (version 10). Scale bar represents 50 µ m.CC BY · PubMed Central
Figure 8 Quantitative analysis of live/dead stained honey treated biofilms. The established S. aureus NCTC 8325 biofilm was treated with New Zealand honeys (manuka honey, Medihoney, manuka/kanuka honey, and clover honey) and a sugar solution at 1%, 2%, 16%, and 32% (w/v) concentrations. Biofilms were co-stained with Syto9 (S, viable cells) and propidium iodide (P, dead cells) and analyzed using COMSTAT. The estimated live (S) and dead (P) biomass (volume of the biofilm over the surface area (µm3/µm2)) are expressed as a percentage of the non-treated control live and dead biomass, which is set at 100%. Error bars represent ±standard deviation (SD) of three biological samples where eight representative images were acquired. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.
Figure 8 Quantitative analysis of live/dead stained honey treated biofilms. The established S. aureus NCTC 8325 biofilm was treated with New Zealand honeys (manuka honey, Medihoney, manuka/kanuka honey, and clover honey) and a sugar solution at 1%, 2%, 16%, and 32% (w/v) concentrations. Biofilms were co-stained with Syto9 (S, viable cells) and propidium iodide (P, dead cells) and analyzed using COMSTAT. The estimated live (S) and dead (P) biomass (volume of the biofilm over the surface area (µm3/µm2)) are expressed as a percentage of the non-treated control live and dead biomass, which is set at 100%. Error bars represent ±standard deviation (SD) of three biological samples where eight representative images were acquired. Statistical significance (p < 0.05) was assessed by One-Way ANOVA with Tukey test after confirming normality of the data set for each treatment using the D’Agnostino-Pearson normality test.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 17 Not checked · 90 Own results and interpretations

60 more claims

Create a free account to see all 107 claims and to verify the 32 references still open.

See all claims — free account
  • It may state two separate claims as one. 36
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. Cooper R Using honey to inhibit wound pathogens Nursing Times 46 2008 104 48 49 18293880

Cited by

See all 184

Metadata

Authors
Lu, J., Turnbull, L., Burke, C. M., Liu, M., Carter, D. A., Schlothauer, R. C., Whitchurch, C. B., & Harry, E. J.
Affiliations
  • The ithree institute, University of Technology Sydney, Sydney, NSW, Australia
  • University of Technology Sydney (AU)
  • The University of Sydney (AU)
  • Comvita (New Zealand) (NZ)
Corresponding author
Harry, Elizabeth J.
Venue
PeerJ
Publisher
PeerJ
Published
2014-03-25
Volume
2
Pages
e326
ISSN
2167-8359 (ISSN-L)
OpenAlex
W2013770888
Cited by
184
References
62
Citations by year
2026: 5 · 2025: 10 · 2024: 12 · 2023: 14 · 2022: 13 · 2021: 19 · 2020: 25 · 2019: 19 · 2018: 16 · 2017: 14 · 2016: 20 · 2015: 10 · 2014: 7
FWCI
13.74
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • PeerJ (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • OPUS - Open Publications of UTS Scholars (University of Technology Sydney) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • University of Technology Sydney
  • Comvita
  • Australian Research Council (LP0990949)
  • National Health and Medical Research Council (571905)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Insect Science › Bee Products Chemical Analysis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
manuka honey, Staphylococcus aureus, biofilm eradication, antibiofilm activity, methylglyoxal, hydrogen peroxide, chronic wounds, methicillin-resistant Staphylococcus aureus, antibiotic resistance, clover honey

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities. https://app.cochat.ai/papers/10.7717/peerj.326
The paper
Lu, J., Turnbull, L., Burke, C. M., Liu, M., Carter, D. A., Schlothauer, R. C., Whitchurch, C. B., & Harry, E. J. (2014). Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities. PeerJ. https://doi.org/10.7717/peerj.326

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.